These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8391927)

  • 1. Characteristic mucinous ovarian cancer antigen is expressed in malignantly transformed Bloom's syndrome cells.
    Shiraishi Y; Yamamoto K; Soma H
    Cancer Res; 1993 Jul; 53(14):3427-32. PubMed ID: 8391927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Panning and immune electron-microscopic study of mucinous ovarian-cancer antigen-specific cells derived from malignantly transformed bloom-syndrome B-lymphoblastoid cells.
    Shiraishi Y; Ozawa M; Yamamoto K; Yagyu K; Nakayama K; Sagara Y; Takakusu A
    Int J Oncol; 1994 Jun; 4(6):1183-9. PubMed ID: 21567035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant lymphoma antigen expressed in nude mouse tumor cells derived from carcinogen-transformed Bloom's syndrome B-lymphoblastoid cell lines.
    Shiraishi Y; Moriki T; Hara H; Araki K; Kozuru M; Sandberg AA
    Cancer Res; 1990 May; 50(10):3106-12. PubMed ID: 2185881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of mucinous ovarian-cancer antigen in hybrid-cells derived by fusing a malignantly transformed bloom-syndrome cell-line (bs-shi-4m ovc-mu) and mouse L-cell-line.
    Shiraishi Y; Taguchi T; Seguchi H
    Int J Oncol; 1995 Dec; 7(6):1275-8. PubMed ID: 21552960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer antigens are expressed in a carcinogen-transformed Bloom syndrome B-lymphoblastoid cell line.
    Shiraishi Y; Soma H
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8211-5. PubMed ID: 3186719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
    McCluggage WG; Young RH
    Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients.
    Chinni SR; Falchetto R; Gercel-Taylor C; Shabanowitz J; Hunt DF; Taylor DD
    Clin Cancer Res; 1997 Sep; 3(9):1557-64. PubMed ID: 9815843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian metastases of intestinal-type gastric carcinoma: A clinicopathologic study of 4 cases with contrasting features to those of the Krukenberg tumor.
    Lerwill MF; Young RH
    Am J Surg Pathol; 2006 Nov; 30(11):1382-8. PubMed ID: 17063077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal antibody against a tissue polypeptide antigen-related protein from a patient with a signet-ring cell carcinoma of the stomach.
    Pfaff M; O'Connor R; Vollmers HP; Müller-Hermelink HK
    Cancer Res; 1990 Aug; 50(16):5192-8. PubMed ID: 1696168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas.
    Ryuko K; Iwanari O; Kitao M; Moriwaki S
    Gynecol Oncol; 1993 May; 49(2):215-24. PubMed ID: 8504990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic characterization of tumor markers in human ovarian cancer cell lines.
    Kutteh WH; Miller DS; Mathis JM
    J Soc Gynecol Investig; 1996; 3(4):216-22. PubMed ID: 8796833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part I. Historical perspective, general principles, mucinous tumors including the krukenberg tumor.
    Young RH
    Adv Anat Pathol; 2006 Sep; 13(5):205-27. PubMed ID: 16998315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of stomach cancer antigen derived from malignantly transformed bloom syndrome cells previously labeled with bromodeoxyuridine.
    Shiraishi Y; Ogata T; Soma H
    Cancer Genet Cytogenet; 1992 Aug; 62(1):1-8. PubMed ID: 1521223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signet-ring stromal tumor of the ovary: clinicopathologic analysis and comparison with Krukenberg tumor.
    Vang R; Bagué S; Tavassoli FA; Prat J
    Int J Gynecol Pathol; 2004 Jan; 23(1):45-51. PubMed ID: 14668550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical analysis of human ovarian cancer-associated antigens defined by murine monoclonal antibodies.
    Miotti S; Aguanno S; Canevari S; Diotti A; Orlandi R; Sonnino S; Colnaghi MI
    Cancer Res; 1985 Feb; 45(2):826-32. PubMed ID: 2981614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
    Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.
    Suzuki N; Aoki D; Tamada Y; Susumu N; Orikawa K; Tsukazaki K; Sakayori M; Suzuki A; Fukuchi T; Mukai M; Kojima-Aikawa K; Ishida I; Nozawa S
    Gynecol Oncol; 2004 Nov; 95(2):290-8. PubMed ID: 15491748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.